Ann: Initial FDA and EMA Advice on Presendin Development, page-143

this is my theory
Sell down nothing to do with tech , success or otherwise
I wonder if there is a seller ie the beneficiary from this transaction ??
I have no idea why Warambi Sarl was liquidated .
Maybe once the stock flushed out then up we go .


I have really nothing to base this on - just a maybe


INVEX THERAPEUTICS
Dr Jason Loveridge has ceased to be a substantial shareholder in Invex.
The London-based Dr Loveridge said that his 3,336,000 share-holding was diluted on May 28, 2020 through the $26.2 million placement at $1.30 a share and through the liquidation of Warambi Sarl and transfer of a 50 percent interest of 1,770,000 shares to another shareholder for $277,927 or 15.7 cents a share.

This was in Biotech Daily 2 June